STOCKS TELEGRAPH

Tag: Zomedica Corp.

  • 2021 Revenue & Gross Margin Updates: Zomedica Corp. (ZOM) stock Rebounds After hours

    2021 Revenue & Gross Margin Updates: Zomedica Corp. (ZOM) stock Rebounds After hours

    On February 25, Zomedica Corp. (ZOM) provided its Q4 and fiscal 2021 revenue and gross margin update. Consequently, the stock rebounded in the after-hours on Friday.

    During the regular trading session, the stock suffered a loss of 3.32% at 37.86 million shares. ZOM closed the session at $0.35 per share after fluctuating between $0.34 and $0.38 during the session. Following the announcement, the stock made a comeback in the after-hours to gain a good 15.92%. Hence, ZOM was trading at a value of $0.40 per share at an after-hours volume of 14.48 million shares, on Friday.

    The veterinary health company, Zomedica Corp. was founded in 2013. Currently, its 979.89 million outstanding shares trade at a market capitalization of $342.18 million. ZOM stock has added a value of 13.93% year to date, while it subtracted a huge 81.33% last year.

    ZOM’s Revenue & Gross Margin

    For the fourth quarter and fiscal 2021, the company reported total revenue of $4.1 million, against $0 in the same periods of the previous year. Moreover, ZOM had a gross margin of 73.9% and cash and cash equivalents were $195 million at the end of 2021.

    In Q4, PluseVet’s revenue increased by 66% YOY to $4.0 million, against $2.4 million in the year-ago period.

    Furthermore, the TRUFORMA® product revenue increased by 22$ to $73,000 in Q4 2021, against $22,500 in the previous quarter.

    The company will release its complete Q4 and fiscal 2021 results on March 1, 2022. Additionally, the company’s progress and future outlook will be discussed during its Q1 Virtual Investor Summit on March 8, 2022.

    Management Team Additions

    Recently, the company announced multiple new additions to its management team, including:

    Firstly, on February 15, ZOM announced the appointment of Adrian Lock, Vice President, and General Manager, for leading its sales organization. Mr. Lock is the founding CEO of PluseVet and has been directing the company’s sales activities for over 10 years.

    Secondly, on February 07, with more than 25 years of experience, Nicole Westfall joined ZOM as the Vice President, Marketing.

    Thirdly, on January 25, with over 30 years of experience, Kristin Domanski was appointed as the Vice President, Human Resources of the company.

    And, on January 2, Tony Blair was appointed as the Executive Vice President, Operations, who comes with over 35 years of experience.

    In addition, Mr. Evan Saint-Peter has been promoted to the role of Vice President, Technology Innovation.

  • Zomedica Corp. (ZOM) Stock Gaining Momentum in Premarket. Here’s What’s Happening.

    Zomedica Corp. (ZOM) Stock Gaining Momentum in Premarket. Here’s What’s Happening.

    Zomedica Corp. (ZOM) is veterinary wellness and health-based company. It offers diagnostics and treatments for pets by fixing their unmet medical needs. The company’s product line includes novel diagnostics and devices, which are intended to improve the health of patients.

    The price of ZOM stock during the regular trading on February 17, 2022, was $0.40 with a gain of 5.26%. At last check in the premarket on February 18, 2022, the stock was further up by 7.17%.

    ZOM: Events and Happenings

    ZOM updated about its Executive management’s participation at the following events.

    • Midwest Veterinary Conference held on February 17-19, 2022.
    • Music City Veterinary Conference being held on February 18-20, 2022, and
    • Q4 Earnings Release Conference is being held on February 25, 2022.

    On February 15, 2022, ZOM updated that the Company’s sales organization is now led by Adrian Lock. He was Vice President and General Manager of the company and will lead sales management and professional service veterinarians. On January 27, 2022, ZOM provided an update on its business and marketing activities in Q1 2022. On December 15, 2021, ZOM announced its Executive management’s presence at the Virtual H.C. Wainwright BioConnect 2022 Conference held on 10-13, 2022.

    ZOM: Key Financials

    On November 12, 2021, ZOM released its financial results for the third fiscal quarter 2021 ended September 30, 2021. Some of the key updates are mentioned below.

    Revenue

    Net revenue in Q3 2021 was $22.5 thousand compared to no revenue in the same quarter of 2020. The company reported an increase in its revenue over the year.

    EPS

    Basic and diluted net loss per share in Q3 2021 was $6.34 million or $0.01 against $4.97 million or $0.01 in the same quarter of 2020. The net loss of the company increased over the yearly period.

    On October 01, 2021, ZOM was informed about the acquisition of Pulse Veterinary Technologies for $70.9 million. Pulsevet is a leading electro-hydraulic shock wave technology for the treatment of a wide range of veterinary patients.

    Conclusion

    ZOM stock down-performed by 81% in the past year as the economic turmoil surrounded the international businesses due to pandemics. The current stock market gain by the company is likely the result of its announcement related to attendance of veterinary conferences and earnings release calls.

  • What Is Raising The ZOM Stock Up Pre Market?

    What Is Raising The ZOM Stock Up Pre Market?

    The shares of Zomedica Corp. (ZOM) have increased 4.51% to $0.7420 in premarket trading as of last check. Zomedica stock ended Thursday’s session down -3.43% at $0.71. There were 24.42 million shares traded which was below the average daily volume of 34.07 million shares during the past 50 days. Zomedica has a current market capitalization of $721.74 million, and its outstanding shares amount to 977.81 million. After providing an update on the company’s performance, ZOM stock has been rising.

    ZOM has updated what?

    Zomedica is a veterinary health company based in Ann Arbor, Michigan, that focuses on meeting the unmet needs of clinical veterinarians. ZOM intends to offer a product portfolio that emphasizes both patient and practitioner health by developing innovative diagnostics and medical devices. Zom is committed to helping veterinarians increase productivity and increase revenue while improving the care of animals.

    The veterinary health company, Zomedica, that designs point-of-care diagnostic products for both dogs and cats, has issued the following corporate update:

    • ZOM’s flagship product, TRUFORMA, will offer five initial assays to detect adrenal and thyroid disorders, followed by several more assays that will cover numerous diseases.
    • As of now, three of ZOM’s initial tests are available.
    • Since its development partner, Qorvo Biotechnologies, is yet to complete the fT4 and ACTH assays, ZOM wants to encourage veterinarians to adopt the TRUFORMA platform in order to test it.
    • ZOM is undertaking this effort now and will continue until the summer of 2021.
    • ZOM is also actively recruiting top-level representatives, professional services veterinarians, and support staff so that it can effectively execute its instrument placement programs and prepare for a significant increase in sales once fT4 and ACTH is available for purchase.
    • ZOM plans to hire fifteen direct sales representatives by the end of 2021, as well as four veterinarians who will perform professional services, as well as inside sales representatives and customer service personnel.
    • The fT4 assay is expected to hit the market in late September or early October, followed two months later by ACTH.
    • In addition, three new tests (cPL, Cobalamin, and Folate) are under development to diagnose gastro-intestinal conditions.

    ZOM’s further efforts:

    Currently, Ziomedica (ZOM) and Qorvo are discussing when and how further assays will be developed after those already identified. It is also expected that ZOM’s TRUFORMA will be available in select markets outside the United States in 2022. Zomedica employees in Michigan have also returned to working on-premises beginning July 6, 2021.

  • 35 stocks making the biggest moves premarket today

    35 stocks making the biggest moves premarket today

    FuelCell Energy Inc. (FCEL) stock soared 4.75% to $10.15 in the pre-market trading. The most recent rating by JP Morgan, on November 19, 2020, is a Neutral.

    SCWorx Corp. (NASDAQ: WORX) shares are trading down -6.76% at $2.07 at the time of writing. Company’s 52-week ranged between $1.00 to $14.88.

    Nano Dimension Ltd. (NNDM) lost over -12.1% at $5.74 in pre-market trading Monday, November 30, 2020, after announcing that it has entered into definitive agreements with investors for the sale of 11,960,160 of the Company’s American Depositary Shares (“ADSs”) at a price of $5.00 per ADS pursuant to a registered direct offering.

    Moderna Inc. (MRNA) is up more than 9.38% at $138.95 in pre-market hours on Monday, November 30, 2020 after the firm today announced that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The data analysis indicates a vaccine efficacy of 94.1%. The stock had jumped over 16.35% to $127.03 in the last trading session.

    FreightCar America Inc. (NASDAQ: RAIL) shares are trading down -3.99% at $2.65 at the time of writing. Company’s 52-week ranged between $0.73 to $2.87. Analysts have a consensus price target of $4.50.

    Blink Charging Co. (BLNK), a Specialty Retail company, dropped about -3.25% at $27.09 in pre-market trading Monday. The firm recently declared that it has acquired the EV charging operator U-Go Stations, Inc. and its portfolio of 44 DCFC charging locations.

    Zomedica Corp. (ZOM), a Drug Manufacturers – Specialty & Generic company, dropped about -1.12% at $0.1324 in pre-market trading Monday.

    GameStop Corp. (GME) is up more than 4.1% at $16.74 in pre-market hours Monday November 30, 2020 after declaring 2020 cyber week deals. The stock had jumped over 9.02% to $16.08 in the last trading session. GameStop Announces 2020 Cyber Week Deals.

    Riot Blockchain Inc. (RIOT) grew over 8.64% at $6.79 in pre-market trading today.

    Verastem Inc. (VSTM) stock moved up 5.03 percent to $2.09 in the pre-market trading after reporting the initiation of a Phase 2 registration-directed clinical trial of VS-6766, its RAF/MEK inhibitor, and defactinib, its FAK inhibitor, in patients with recurrent low-grade serous ovarian cancer (LGSOC).

    Tuniu Corporation (TOUR) gained over 6.58% at $3.4 in pre-market trading on Monday, November 30, 2020. Before the trading started on November 30, 2020.

    Novavax Inc. (NVAX) is down -8.31% to reach $115.25 after providing an update on its COVID-19 vaccine program. NVX‑CoV2373 is a stable, prefusion protein antigen derived from the genetic sequence of the SARS-CoV-2 coronavirus spike (S) protein and adjuvanted with Novavax’ proprietary Matrix‑M™. It has been trading in a 52-week range of $3.65 to $189.40.

    Occidental Petroleum Corporation (NYSE: OXY) shares are trading down -2.36% at $16.17 at the time of writing. Company’s 52-week ranged between $8.52 to $47.58. Analysts have a consensus price target of $18.

    RMG Acquisition Corp. (RMG) stock soared 6.6% to $18.1 in the pre-market trading. The firm recently revealed that the close of business on Tuesday, December 1, 2020, has been set as the record date for the determination of stockholders eligible to receive the proxy and vote at the special meeting to be held to consider and approve the previously announced merger with Romeo Systems, Inc., a Delaware corporation.

    Uxin Limited (UXIN) stock soared 2.53% to $1.62 in the pre-market trading. The most recent rating by JP Morgan, on October 23, 2019, is a Neutral.

    ReneSola Ltd (NYSE: SOL) shares are trading up 8.02% at $8.08 at the time of writing. The technology company recently announced the closing of the sale of a portfolio of operating projects located in the United Kingdom to Atmosclear Investments Ltd, an European renewable energy and cleantech private equity group. Company’s 52-week ranged between $0.85 to $5.67. Analysts have a consensus price target of $22.

    Kandi Technologies Group Inc. (KNDI) tumbled over -2.28% at $13.31 in pre-market trading today after CBAK Energy and Kandi Group signed a supply framework agreement.

    Vaxart Inc. (VXRT) is up more than 4.84% at $7.37 in pre-market hours on Monday, November 30, 2020. The stock had jumped over 9.84% to $7.03 in the last trading session. Before the trading started on November 30, 2020.

    Alibaba Group Holding Limited (BABA) is down -2.3% to reach $270.13. The internet retail company has been named a leader in Gartner’s 2020 Magic Quadrant for Cloud Database Management Systems. It has been trading in a 52-week range of $169.95 to $319.32.

    EyePoint Pharmaceuticals Inc. (EYPT) stock soared 1.97% to $0.55 in the pre-market trading. The most recent rating by B. Riley FBR, on April 06, 2020, is a Neutral.

    Canaan Inc. (NASDAQ: CAN) shares are trading down -7.83% at $5.3 at the time of writing after releasing its unaudited financial results for the three months ended September 30, 2020. Company’s 52-week ranged between $1.76 to $8.69.

    Heat Biologics Inc. (NASDAQ: HTBX) shares are trading down -0.88% at $1.13 at the time of writing. Company’s 52-week ranged between $0.19 to $4.30. Analysts have a consensus price target of $4.

    Yunji Inc. (YJ), an Internet Retail company, dropped about -7.35% at $3.53 in pre-market trading Monday. The firm recently declared its unaudited financial results for the third quarter ended September 30, 2020.

    India Globalization Capital Inc. (IGC) gained over 22.63% at $2.33 in pre-market trading Monday November 30, 2020.

    Oramed Pharmaceuticals Inc. (ORMP) stock moved up 38.65 percent to $6.17 in the pre-market trading. The healthcare firm recently reported that it has screened the first patients in its global Phase 3 trials of its oral insulin capsule ORMD-0801 for the treatment of type 2 diabetes (T2D). Before the trading started on November 30, 2020.

    Schlumberger Limited (SLB) is down -2.06% to reach $21.43. It has been trading in a 52-week range of $11.87 to $41.14.

    Ocugen Inc. (OCGN) stock plunged -1.71% to $0.294 in the pre-market trading. The firm recently revealed that Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen, will speak on “The Promise of Cell & Gene Therapies: Regulatory and Reimbursement Roadblocks” at Xconomy’s Xcelerating Life Sciences New York & Philadelphia Virtual Event on December 3 at 10:30 a.m. Before the trading started on November 30, 2020.

    Gold Fields Limited (GFI) is down -2.52% to reach $8.5. It has been trading in a 52-week range of $3.79 to $14.90. Before the trading started on November 30, 2020.

    Marathon Patent Group Inc. (MARA) is up 15.65% to reach $4.95. It has been trading in a 52-week range of $0.35 to $6.05.

    Kingsoft Cloud Holdings Limited (KC) stock soared 5.13% to $43.69 in the pre-market trading after reporting that it will be included in the MSCI China Index, effective after the U.S. market close on November 30, 2020. The most recent rating by Goldman, on June 29, 2020, is a Buy.

    NanoVibronix Inc. (NASDAQ: NAOV) shares are trading up 5.26% at $0.8 at the time of writing. Company’s 52-week ranged between $0.54 to $3.50.

    Waitr Holdings Inc. (WTRH) stock moved down -1.46 percent to $3.38 in the pre-market trading.

    Hennessy Capital Acquisition Corp. IV (HCAC) gained over 9.0% at $13.69 in pre-market trading on Monday, November 30, 2020.

    Trevena Inc. (TRVN) stock plunged -4.67% to $2.45 in the pre-market trading. The most recent rating by Guggenheim, on September 14, 2020, is a Buy.

    Suncor Energy Inc. (NYSE: SU) shares are trading down -0.58% at $17.15 at the time of writing. The firm lately publicized that it, together with the other Syncrude joint venture owners – Imperial Oil Resources Limited, CNOOC Oil Sands Canada, and Sinopec Oil Sands Partnership – have agreed in principle for Suncor to become the operator of the Syncrude project by the end of 2021. Company’s 52-week ranged between $9.60 to $34.56.

  • 23 stocks making the biggest moves in the premarket today

    23 stocks making the biggest moves in the premarket today

    DPW Holdings Inc. (DPW) stock soared 2.5% to $7.37 in the pre-market trading after the company revealed that its power electronics business, Coolisys Technologies Corp., has established a program targeting both national and regional fast-food franchises to install the ACECool™ electric vehicle (“EV”) chargers as a part of a revenue sharing program.

    Naked Brand Group Limited (NASDAQ: NAKD) shares are trading up 9.19% at $0.2008 at the time of writing. Company’s 52-week ranged between $0.07 to $4.00.

    Ideanomics Inc. (IDEX) grew over 15.27% at $3.02 in pre-market trading today. The firm reported that it has increased its stake in California-based Solectrac, Inc. through a follow-on investment of an additional $1.3 million.

    Sundial Growers Inc. (SNDL), a Drug Manufacturers – Specialty & Generic company, rose about 72.38% at $0.4151 in pre-market trading Tuesday. The company recently publicized that it will participate in Cowen’s 2020 Boston Cannabis Conference, to be held virtually between November 30 and December 2, 2020.

    Li Auto Inc. (NASDAQ: LI) shares are trading up 6.99% at $46.69 at the time of writing. Company’s 52-week ranged between $14.31 to $40.81. Analysts have a consensus price target of $45.60.

    Tantech Holdings Ltd (TANH) grew over 23.36% at $2.64 in pre-market trading today following the firm declared that it has entered into a securities purchase agreement with institutional investors to purchase approximately $10 million of its common shares and registered warrants to purchase common shares in a registered direct offering as well as unregistered warrants to purchase common shares in a concurrent private placement.

    Marathon Patent Group Inc. (MARA), a Capital Markets company, rose about 16.26% at $5.72 in pre-market trading Tuesday.

    Ayro Inc. (AYRO) lost over -5.75% at $9.99 in pre-market trading Tuesday November 24, 2020 after the firm revealed that it has entered into definitive agreements with Carnegie Hudson Resources, an investment arm of Wanxiang America, and several existing institutional investors.

    Carnival Corporation & Plc (CCL) is up more than 6.49% at $19.36 in pre-market hours Tuesday November 24, 2020 after the recent declaration that the company has closed its previously announced registered direct offering of 10.4 million shares of its common stock at a price of $17.59 per share to a holder of its 5.75% Convertible Senior Notes due 2023.  The stock had jumped over 4.66% to $18.18 in the last trading session.

    Before the trading started on November 24, 2020, Occidental Petroleum Corporation (OXY) is up 7.42% to reach $16.93. It has been trading in a 52-week range of $8.52 to $47.58.

    Fuel Tech Inc. (FTEK) stock soared 57.45% to $4.44 in the pre-market trading. The most recent rating by H.C. Wainwright, on March 13, 2020, is a Neutral.

    Kandi Technologies Group Inc. (NASDAQ: KNDI) shares are trading up 8.17% at $16.15 at the time of writing as the firm publicized that it closed the registered direct offering of 8,849,560 units (the “Units”) of its securities at a purchase price per Unit of $11.30 on November 23, 2020, as previously announced on November 20, 2020. Company’s 52-week ranged between $2.17 to $17.40.

    Tilray Inc. (TLRY) grew over 19.31% at $7.97 in pre-market trading today after company’s publication that it has entered into a privately negotiated exchange agreement with a certain holder of its 5.00% Convertible Senior Notes due 2023.

    Barrick Gold Corporation (GOLD), a Gold company, dropped about -2.67% at $22.62 in pre-market trading Tuesday after Loncor Resources provided an update on its exploration activities within the Ngayu greenstone belt, where the Company has a joint venture with Barrick Gold (DRC) Limited as well as its own majority-owned projects.

    Switchback Energy Acquisition Corporation (SBE) grew over 20.04% at $40.91 in pre-market trading today.

    iBio Inc. (IBIO), a Biotechnology company, dropped about -3.4% at $1.42 in pre-market trading Tuesday. The healthcare company recently reported that the United States Patent and Trademark Office has issued U.S. Patent No. 10,844,392, entitled “Materials and Methods for Producing Endostatin Fusion Polypeptides in Plant Cells,” which, amongst other claims, covers a novel expression cassette that enhances the yield of endostatin fragments and variants using iBio’s FastPharming® System.

    Ferroglobe PLC (GSM) stock moved down -13.67 percent to $1.2 in the pre-market trading after the firm declared results for the third quarter of 2020.

    Longview Acquisition Corp. (LGVW) stock soared 24.26% to $16.9 in the pre-market trading.

    Ocean Power Technologies Inc. (NASDAQ: OPTT) shares are trading up 43.32% at $3.11 at the time of writing after the firm proclaimed that Jorge Franco has joined the Company as Regional Sales Representative based in Spain. Reporting to OPT Vice President, Global Sales Jeff Wiener, Mr. Franco will concentrate on opportunities in Southern Europe. Company’s 52-week ranged between $0.33 to $3.72.

    Kosmos Energy Ltd. (KOS) grew over 8.95% at $2.07 in pre-market trading today.

    Before the trading started on November 24, 2020, Ballard Power Systems Inc. (BLDP) is down -3.75% to reach $20.77 following announcement of US$250 million bought deal offering of common shares by the company. It has been trading in a 52-week range of $5.50 to $21.61.

    Bloom Energy Corporation (BE) stock soared 8.61% to $23.98 in the pre-market trading. The most recent rating by Raymond James, on February 20, 2020, is a Mkt perform.

    Energous Corporation (WATT) stock soared 9.13% to $2.51 in the pre-market trading. The most recent rating by Ladenburg Thalmann, on May 01, 2019, is a Buy.

    Canaan Inc. (NASDAQ: CAN) shares are trading up 7.31% at $5.43 at the time of writing. The technology company recently told that it will release its third-quarter 2020 financial results before the market opens on Monday, November 30, 2020. The company’s 52-week ranged between $1.76 to $13.00.

  • Top 15 Healthcare Stocks You Should Add To Your Bucket

    The global generics drug market continues to grow with the increasing demand for more medication. Drug manufacturers are continuously striving to meet the need for more generic drugs. This industry is an opportunity-rich industry. Efficient and inexpensive drugs are often needed. The drug manufacturing industry has seen a huge transformation over the last two decades.

    This industry-main challenge is to provide the drug at lower prices than branded drugs. Drug manufacturers and Specialty Generic Industry will face more pressure in the coming years to lower the prices of drugs.  The industry is expected to grow significantly over the next decade. Check out the leading companies in drug manufacturers- specialty generic industry to see how these are addressing the needs of their customers:

    Sundial Growers Inc. (NASDAQ: SNDL)

    Sundial Growers Inc. (NASDAQ: SNDL) shares were trading down -6.32% at $0.17 at the time of writing on Wednesday. Sundial Growers Inc. (NASDAQ: SNDL) share price went from a low point around $0.17 to briefly over $4.12 in the past 52 weeks, though shares have since pulled back to $0.17. SNDL market cap has remained high, hitting $32.59M at the time of writing, giving it a price-to-sales ratio of more than 0.

    Sundial Growers Inc. (SNDL) has revealed earlier that it has expanded the Palmetto brand presence across Canada. If we look at the recent analyst rating SNDL, CIBC upgraded coverage on SNDL shares with a Neutral rating.

    Teligent Inc. (NASDAQ: TLGT)

    Teligent Inc. (NASDAQ: TLGT) last closed at $1.04, in a 52-week range of $0.65 to $8.00. The Schall Law Firm has earlier revealed that it is investigating claims on behalf of investors in Teligent, Inc. for potential breaches of fiduciary duty on the part of its directors and management. Teligent Inc.’s market cap has remained high, hitting $5.68 Million at the time of writing.

    Zomedica Corp. (AMEX: ZOM)

    Zomedica Corp. (AMEX: ZOM) stock drop by -3.82% to $0.08. Zomedica Corp. (ZOM) revealed that it has changed its legal name to Zomedica Corp. The Company’s stock trading symbol will remain as ZOM on the NYSE American and the shares will start trading under the new name effective on October 5, 2020.

    Aurora Cannabis Inc. (NYSE: ACB)

    Aurora Cannabis Inc. (NYSE: ACB) shares headed rising, higher as much as 6.36%. The most recent rating by Jefferies, on September 21, 2020, is at a Hold. Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of Aurora Cannabis Inc. (ACB) shareholders.

    Tilray Inc. (NASDAQ: TLRY)

    Tilray Inc. (NASDAQ: TLRY) rose 2.96% after gaining more than $0.19 on Wednesday. Tilray Inc. (TLRY) earlier revealed that its wholly-owned subsidiary, High Park Holdings Ltd. has introduced the newest addition to its cannabis-infused edible product line: Chowie Wowie Gummies, which are now available in select provinces across Canada.

    Neos Therapeutics Inc. (NASDAQ: NEOS)

    Neos Therapeutics Inc. (NASDAQ: NEOS) last closed at $0.86, in a 52-week range of $0.45 to $1.98. Neos Therapeutics Inc. (NEOS) has reported that its sales in quarter two reached $13.13 million. However, earnings dropped by 51.17%, resulting in a loss of $2.88 million. In Q1, Neos Therapeutics brought in $14.49 million in sales but lost $5.89 million in earnings.

    Teva Pharmaceutical Industries Limited (NYSE: TEVA)

    Teva Pharmaceutical Industries Limited (NYSE: TEVA) shares headed rising, higher as much as 3.72%. The most recent rating by Barclays, on August 06, 2020, is at an Equal-weight. Pomerantz LLP revealed that a class action lawsuit has been lodged against Teva Pharmaceuticals Industries Limited and certain of its officers.

    Elanco Animal Health Incorporated (NYSE: ELAN)

    Elanco Animal Health Incorporated (NYSE: ELAN) shares headed falling, lower as much as -2.56%. The most recent rating by Morgan Stanley, on August 20, 2020, is at an Overweight. Elanco Animal Health Incorporated (ELAN) has revealed that it has got a notification of an unsolicited ‘mini-tender”‘ offer by TRC Capital Investment Corporation to buy up to 4,000,000 shares of Elanco common stock, representing approximately 1.00% of the outstanding shares of Elanco common stock.

    HEXO Corp. (NYSE: HEXO)

    HEXO Corp. (NYSE: HEXO) fall -0.91% after losing more than -$0.01 on Wednesday. HEXO Corp. (HEXO) has earlier disclosed that it has appointed Trent MacDonald to its executive leadership team in the acting role of Chief Financial Officer, effective October 10, 2020. Its market cap has remained high, hitting $365.78 million at the time of writing.

    Bausch Health Companies Inc. (NYSE: BHC)

    Bausch Health Companies Inc. (BHC) last closed at $17.57, in a 52-week range of $11.15 to $31.97. Analysts have a consensus price target of $26.76. Bausch Health Companies Inc. (BHC) and Lomb, its leading global eye health business, along with BHVI, revealed previously that an affiliate of Bausch Health has bought an exclusive license for a myopia control contact lens design developed by BHVI.

    Endo International plc (NASDAQ: ENDP)

    Endo International plc (NASDAQ: ENDP) stock drop by -5.69% to $5.47. The most recent rating by Goldman, on July 27, 2020, is at a Sell. Endo International plc (ENDP) revealed that it has decided to buy all of the outstanding shares of BioSpecifics Technologies Corp. for $88.50 in cash per share or an estimated enterprise value of approximately $540 million at the expected time of deal closure.

    China SXT Pharmaceuticals Inc. (NASDAQ: SXTC)

    China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) stock soar by 9.65% to $0.31. China SXT Pharmaceuticals Inc. (SXTC) share has fluctuated between the 52-weeks low of $0.22 and 52-weeks high of $1.56 during the trading session of Wednesday. It has moved up 40.64% from its 52-weeks low and moved down -79.97% from its 52-weeks high.

    Canopy Growth Corporation (NYSE: CGC)

    Canopy Growth Corporation (NYSE: CGC) rose 3.23% after gaining more than $0.61 on Wednesday. Canopy Growth Corporation (CGC) share price went from a low point around $9.00 to briefly over $25.97 in the past 52 weeks, though shares have since pulled back to $19.49. CGC market cap has remained high, hitting $7.24 billion at the time of writing.

    Aphria Inc. (NASDAQ: APHA)

    Aphria Inc. (NASDAQ: APHA) last closed at $4.68, in a 52-week range of $1.95 to $6.44. Aphria Inc. (APHA) has moved up 140.00% from its 52-weeks low and moved down -27.33% from its 52-weeks high. Its market cap has remained high, hitting $1.25 billion at the time of writing.

    China Pharma Holdings Inc. (CPHI)

    China Pharma Holdings Inc. (CPHI) stock soar by 6.86% to $0.50. The most recent rating by Rodman & Renshaw, on January 08, 2010, is at an Mkt outperform. China Pharma Holdings Inc. (CPHI) has moved up 134.13% from its 52-weeks low and moved down -64.53% from its 52-weeks high. Its market cap has remained high, hitting $22.72 million at the time of writing.